LEVEL FOUR ADVISORY SERVICES, LLC
Position in JUNS — Jupiter Neurosciences, Inc.
CIK 1696715
DALLAS, TX
Position in JUNS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$28
New position
Shares Held
133
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 13 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $9,160,165 across 9 Biotechnology names. JUNS ranks #9 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,034 | $4,984,188 | |
| 2 | GMAB |
Genmab A/S
|
58,000 | $1,593,260 | |
| 3 | ARGX |
Argenx SE
|
1,148 | $1,065,079 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
3,490 | $840,985 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
5,506 | $312,795 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
396 | $246,921 | |
| 7 | MNKD |
Mannkind Corp
|
21,338 | $90,899 | |
| 8 | OCGN |
Ocugen, Inc.
|
17,000 | $26,010 |
All Filings in JUNS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28 | 10,000 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||